The role of AIM2 in human hepatocellular carcinoma and its clinical significance
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Panpan Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China; Jiangsu Engineering Research …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: AIM2 (absent in melanoma 2) was first discovered as the gene which was not expressed in melanoma cells. It is established that the AIM2 inflammasome function as the double-stranded DNA (dsDNA) sensor, and it plays a crucial role in infectious disorders and cancer. Little is known about the AIM2 expression pattern and its clinical significance in human hepatocellular carcinoma (HCC), understating how AIM2 altered the HCC cells is of high clinical interest. METHODS: Immunohistochemistry was performed to investigate the AIM2 expression in HCC tissues. Then we constructed the ectopic AIM2-expressed HCC cell line by lentiviral transduction. Biological functional assays were used to analyze the clinical significance of AIM2. RESULTS: AIM2 expression was significantly decreased in human HCC tissues compared with adjacent normal tissues, and the overall survival of HCC patients with higher AIM2 expression was significantly better. Ectopic expression of AIM2 in HCC cells significantly inhibited migration and promoted apoptosis. Furthermore, our study revealed that the notch signaling pathway could be involved in the regulation of AIM2 in the cellular network in HCC cells. AIM2 delayed the tumor progression and correlated with immune cell infiltration. CONCLUSION: In this study, we suggested AIM2 played an inhibitory role in regulating the growth and metastasis of HCC, which supported the notion that AIM2 could serve as a potential therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China; Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou 213003, China; Institute of…
- Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou 213003, China; Institute of Cell Therapy, Soochow University, Changzhou 213003, China.
- Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215006, China.
- Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China; Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou 213003, China. Electronic ad…
Zitieren
APA
Zheng, P., Xiao, W., Zhang, J., Zheng, X., & Jiang, J. (2023). The role of AIM2 in human hepatocellular carcinoma and its clinical significance. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154454
Vancouver
Zheng P, Xiao W, Zhang J, Zheng X, Jiang J. The role of AIM2 in human hepatocellular carcinoma and its clinical significance. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154454
BibTeX
@article{Zheng2023,
author = {Zheng, Panpan and Xiao, Wenlu and Zhang, Jinping and Zheng, Xiao and Jiang, Jingting},
title = {The role of AIM2 in human hepatocellular carcinoma and its clinical significance},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154454}
}
EUVIMED